ArticleCureus2026
Azathioprine-Induced Eosinophilia and Acute Cholestatic Hepatitis in Lupus Nephritis: An Early Hypersensitivity-Mediated Presentation of Thiopurine-Associated Drug-Induced Liver Injury.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Azathioprine is a thiopurine immunosuppressive medication widely used in the treatment of autoimmune diseases and organ transplantation. Although hematologic toxicity is well recognized, hepatotoxicity and hypersensitivity reactions are less commonly encountered but clinically significant adverse effects. We present the case of a 20-year-old female with systemic lupus erythematosus and class III lupus nephritis who developed progressive nausea, fatigue, eosinophilia, pancytopenia, and marked transaminase elevation shortly after initiation of azathioprine therapy. Imaging excluded biliary obstruction, while endoscopic and histologic evaluation demonstrated inflammatory changes with eosinophilic infiltration. Liver biopsy confirmed acute intrahepatocellular cholestatic hepatitis. Discontinuation of azathioprine led to rapid biochemical improvement and resolution of eosinophilia. This case highlights an early hypersensitivity-mediated presentation of azathioprine-induced liver injury and underscores the importance of early recognition and prompt drug withdrawal.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.